HPV Beyond Cervical Cancer: A Multidisciplinary Call for Broader Awareness and Prevention

Over 80% of sexually active individuals will contract the human papillomavirus (HPV) at some point in their lives. This statistic underscores the urgent need to address HPV not just as a cause of cervical cancer but as a broader public health concern, as highlighted by a recent multidisciplinary conference in Málaga, Spain.

HPV’s Broader Impact: Beyond Cervical Cancer

The conference, organized by the Gynecology Department of Hospital Quirónsalud Málaga, brought together gynecologists, urologists, and otorhinolaryngologists to discuss HPV’s role in cancers of the anus, vagina, penis, and oropharynx. Dr. Jessica Martín Orlando, a gynecologist and coordinator of the hospital’s Lower Genital Tract Unit, emphasized that HPV is responsible for nearly all cervical cancers and a significant proportion of other malignancies. “The virus affects multiple anatomical sites and requires a global health approach,” she stated.

These figures highlight the need for expanded screening and prevention strategies beyond traditional gynecological care.

HPV in Men: A Critical but Overlooked Population

Despite its prevalence, HPV’s impact on men remains underemphasized. One in three men in the world is infected with some type of genital HPV and one in five presents types considered high risk. Dr. Carlos Bautista, a urologist at Hospital Civil de Málaga, stressed that men are not just carriers but also at risk for HPV-related diseases. Experts argue that expanding vaccination programs and education to include men is critical for reducing overall HPV transmission.

Prevention as the Cornerstone of HPV Control

Dr. Martín Orlando reiterated that vaccination, screening, and specialized follow-up for persistent infections are the most effective tools against HPV-related diseases.

Screening programs remain vital for early detection.

Looking Ahead: A Call for Global Action

The Málaga conference aligns with efforts to combat HPV. Achieving this goal requires addressing HPV’s broader implications, ensuring equitable access to vaccines, and fostering cross-disciplinary collaboration. As Dr. Martín Orlando concluded, “Prevention is not just a medical strategy—it’s a societal imperative.”